• New Chromabond® Drug Ii

Chromatography

New Chromabond® Drug Ii

Macherey Nagel GmbH introduces a specific cartridge for solid phase extraction for enrichment of THC (tetrahydrocannabinol) and THC-derivates from blood or urine. The determination of tetrahydrocannabinol and its metabolites is an important procedure in analysis of drugs of abuse and is offered as standard routine method by many laboratories. After enrichment of the analytes respectively pre-cleaning of the sample by SPE subsequent identification by GC/MS is proceeded.

CHROMABOND® Drug II contains a bifunctional adsorbent material, consisting from a strong anion exchanger (SAX, quaternary amine) and C8 modified silica. Two primary retention mechanisms facilitate the use of very strong interferant eluting solvents resulting in very pure extracts especially from heavily matrix loaded samples like urine, plasma, serum or whole blood.

Already available from Macaherey Nagel is CHROMABOND® Drug a SPE-cartridge for enrichment of acidic, neutral and basic drugs. By introducing CHROMABOND® Drug II the scope of SPE products for drug analysis is widened by the important group of THCs.

Digital Edition

Lab Asia Dec 2025

December 2025

Chromatography Articles- Cutting-edge sample preparation tools help laboratories to stay ahead of the curveMass Spectrometry & Spectroscopy Articles- Unlocking the complexity of metabolomics: Pushi...

View all digital editions

Events

Smart Factory Expo 2026

Jan 21 2026 Tokyo, Japan

Nano Tech 2026

Jan 28 2026 Tokyo, Japan

Medical Fair India 2026

Jan 29 2026 New Delhi, India

SLAS 2026

Feb 07 2026 Boston, MA, USA

Asia Pharma Expo/Asia Lab Expo

Feb 12 2026 Dhaka, Bangladesh

View all events